Launch of Board Certification in Pediatric Infectious Diseases in Japan.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
09 May 2024
09 May 2024
Historique:
medline:
8
5
2024
pubmed:
8
5
2024
entrez:
8
5
2024
Statut:
aheadofprint
Résumé
To cultivate specialists in pediatric infectious diseases (ID) in Japan, the Japanese Society for Pediatric Infectious Diseases initiated board certification for pediatric ID in 2017. Previously, in 2014, we had formed a committee for board certification in pediatric ID and discussed the fundamentals of the board certification system, including the goals, requirements for designated training institutions, provisional certification of pediatric ID specialists and eligibility for and content of the board certification examination. After approval from 31 programs, the pediatric ID programs started in 2017 with 8 fellows in 7 programs. The first 6 graduates received board certification in 2020. To date, 61 pediatricians have been board certified as pediatric ID specialists. In parallel, we introduced board certification for pediatricians who work mainly in primary care settings and have a special interest in pediatric ID. This system has certified 338 pediatricians. During and after the development of the programs, we achieved substantial progress in highlighting the pivotal role of pediatric ID specialists, including the establishment and maintenance of antimicrobial stewardship programs, pediatric ID consultations and introduction of viral diagnosis by polymerase chain reaction at institutions. However, several issues need to be addressed, including the establishment of independent pediatric ID departments in institutions, payment of consultation fees, program site visits, maintenance of certification and cultivation of physician-scientists. These challenges will be the focus of future efforts.
Identifiants
pubmed: 38717154
doi: 10.1097/INF.0000000000004388
pii: 00006454-990000000-00861
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Chen CC, Whitehead A. Emerging and re-emerging infections in children: COVID/MIS-C, Zika, Ebola, Measles, Varicella, Pertussis... immunizations. Emerg Med Clin North Am. 2021;39:453–465.
Medernach RL, Logan LK. The growing threat of antibiotic resistance in children. Infect Dis Clin North Am. 2018;32:1–17.
Larson HJ, Jarrett C, Eckersberger E, et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014;32:2150–2159.
The American Board of Pediatrics. Pediatric Infectious Disease Certification. Available at: https://www.abp.org/content/pediatric-infectious-diseases-certification. Accessed February 26, 2024.
Royal College of Paediatric and Child Health. Infectious Diseases. Available at: https://www.rcpch.ac.uk/topic/infectious-diseases. Accessed February 26, 2024.
European Society for Paediatric Infectious Diseases. PID Training Programme (syllabus). Available at: https://www.espid.org/content.aspx?Group=education&Page=pid_training. Accessed February 26, 2024.
Saitoh A, Ouchi K, Moriuchi H. Introduction of the Japanese Society for Pediatric Infectious Diseases. Pediatr Infect Dis J. 2022;41:e110–e112.
Dellit TH, Owens RC, McGowan JE Jr, et al.; Infectious Diseases Society of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–177.
Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the “vaccine gap?”. Vaccine. 2012;30:4752–4756.
Saitoh A, Okabe N. Recent progress and concerns regarding the Japanese immunization program: addressing the “vaccine gap”. Vaccine. 2014;32:4253–4258.
Japan Pediatric Society. Approach to Simultaneous Vaccination by Japan Pediatric Society (in Japanese). Available at: https://www.jpeds.or.jp/modules/activity/index.php?content_id=127. Accessed February 26, 2024.
The Japanese Society for Infectious DIseases. About the Japanese Society for Infectious DIseases. Available at: https://www.kansensho.or.jp/modules/en/index.php?content_id=1. Accessed February 26, 2024.
Saitoh A, Sakamoto SN, Kamiyama S, Katsuta T, Shoji K, Funaki T, Saito A, Komura M, Ishikawa Y. An antimicrobial stewardship program led to proper dosing and decreased use of antimicrobials: the results from the National Children’s Hospital of Japan. Poster presented at: The 50th Annual Meeting of the Infectious Disease Society of America, San Diego, CA. 2012.
Aizawa Y, Suwa J, Higuchi H, et al. Antimicrobial stewardship program in a pediatric intensive care unit. J Pediatric Infect Dis Soc. 2018;7:e156–e159.
Horikoshi Y, Kaneko T, Morikawa Y, et al. The north wind and the sun: pediatric antimicrobial stewardship program combining restrictive and persuasive approaches in hematology-oncology ward and hematopoietic stem cell transplant unit. Pediatr Infect Dis J. 2018;37:164–168.
Shishido A, Otake S, Kimura M, et al. Effects of a nudge-based antimicrobial stewardship program in a pediatric primary emergency medical center. Eur J Pediatr. 2021;180:1933–1940.
Furuichi M, Furuichi M, Horikoshi Y, et al. Infectious diseases consultation improves treatment and decreases mortality by enterococcal bacteremia in children. Pediatr Infect Dis J. 2018;37:856–860.
Horikoshi Y, Suwa J, Higuchi H, et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis. 2017;64:69–73.
Aizawa Y, Suzuki Y, Watanabe K, et al. Clinical utility of serum samples for human parechovirus type 3 infection in neonates and young infants: the 2014 epidemic in Japan. J Infect. 2016;72:223–232.
Pliakos EE, Ziakas PD, Mylonakis E. Economic analysis of infectious disease consultation for Staphylococcus aureus bacteremia among hospitalized patients. JAMA Netw Open. 2022;5:e2234186.
Mani NS, Lan KF, Jain R, et al. Postprescription review with threat of infectious disease consultation and sustained reduction in meropenem use over four years. Clin Infect Dis. 2021;73:e4515–e4520.
Swartz TH, Apewokin S, Carpenter SM, et al. A call to action: urgently strengthening the future physician-scientist workforce in infectious diseases. J Infect Dis. 2024;229:625–629.